A larger study is needed to better understand the role of different SNPs of ELAC2, other risk factors, and other genes in prostate cancer predisposition, which may benefit early diagnosis of the disease in at-risk individuals and management of the disease. This evidence concerns the gene ELAC2 and Familial prostate cancer.